Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome

Neurology

Volumn 62, Issue 7, 2004, Pages 1233-1234

  Lozsadi, Dora A ^a   Hart, Ian K ^a,b   Moore, A Peter ^a,b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b Lower Lane   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CLONAZEPAM; ETIRACETAM; IMMUNOGLOBULIN; MIDAZOLAM; PHENYTOIN; PREDNISOLONE; TOPIRAMATE; VIGABATRIN;

ADULT; ARTICLE; BRAIN ATROPHY; CASE REPORT; DYSTONIA; EPILEPTIC STATE; HUMAN; INVOLUNTARY MOVEMENT; LIMB MOVEMENT; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RASMUSSEN SYNDROME;

EID: 1842527948     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000118283.51400.7A     Document Type: Article

References (7)

1. Granata T, Gobbi G, Spreafico R, et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003;60:422-425.
2. Frucht S. Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis. Mov Disord 2002;17:609-612.
3. Levite M, Hart IK. Immunotherapy for epilepsy. Expert Rev Neurother 2002;2:809-814.
4. Leach JP, Chadwick DW, Miles JB, Hart IK. Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology 1999;52:738-742.
5. Koehn MA, Zupanc ML. Unusual presentation and MRI findings in Rasmussen's syndrome. Pediatr Neurol 1999;21:839-842.
6. Tarsy D, Schachter SC. Botulinum toxin is not effective for epilepsy partialis continua. Mov Disord 1995;10:357-378.
7. Jost WH, Kohl A. Botulinum toxin: evidence-based medicine criteria in rare indications. J Neurol 2001;248 (suppl 1):39-44.